AtriCure | ATRC - 销售成本



金融业
股票价格
USD
资产
USD 676.64M
现金及等价物
USD 167.79M
销售成本
USD 34.98M
流动资产
USD 345.53M
流动负债
USD 81.92M
债务
USD 71.78M
股息收益率
0
EBIT
USD 9.67M
EBITDA
USD 27.29M
员工
1.3K
EPS每股收益
USD 0.18
股本和储备
USD 516.43M
销售毛利
USD 109.31M
债务利息支出
USD 1.21M
利息收入
USD 1.25M
贷款资金
USD 61M
市值
USD 2.79B
净收入
USD 8.96M
营业费用
USD 143.94M
营业利润
USD 9.67M
普通股股本
USD 50.64M
PE价格收益
129.01
税前利润
USD 394K
销售收入
USD 153.6M
销售和管理费用
USD 82.56M
股票
USD 83.93M
贸易债权人
USD 78.74M
应收帐款人
USD 79.98M


销售成本 更改 日
Abbott USD 5.94B 642M 2026-06
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 34.98M 3.04M 2026-06
Baxter International USD 1.93B 118M 2026-06
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Boston Scientific USD 1.86B 29M 2026-06
Cooper Companies USD 401.3M 7.5M 2026-06
Dexcom USD 478.4M 36.8M 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Globus Medical USD 271M 7.41M 2026-06
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 239.1M 6.4M 2026-06
Integra LifeSciences USD 188.86M 10.15M 2026-06
Intuitive Surgical USD 931.9M 8.4M 2026-06
J&J USD 8B 67M 2026-06
Medtronic USD 3.83B 26M 2026-06
Merit Medical Systems USD 203.68M 6.6M 2026-06
ResMed USD 612.93M 61.26M 2026-06
Stryker USD 2.26B 106M 2026-06
Tandem Diabetes Care USD 109.78M 653K 2026-06
Teleflex USD 238.62M 2.21M 2026-06
Zimmer Biomet Holdings USD 815.9M 77.6M 2026-06